Evidence map›Paper›PMID 37033213›Full record

ArticleFrontiers in endocrinology2023

The ankle in XLH: Reduced motion, power and quality of life.

Celine Akta, Florian Wenzel-Schwarz, Alexandra Stauffer, Andreas Kranzl, Adalbert Raimann, Roland Kocijan, Rudolf Ganger, Gabriel T Mindler

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Switching from active vitamin D and phosphate supplementation to burosumab significantly corrects lower limb malalignment in pediatric X-linked hypophosphatemia.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. What's new in pediatric lower limb reconstruction?Journal of children's orthopaedics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Celine AktaDepartment of Pediatric Orthopaedics, Orthopaedic Hospital Speising, Vienna, Austria.
Florian Wenzel-SchwarzDepartment of Pediatric Orthopaedics, Orthopaedic Hospital Speising, Vienna, Austria.
Alexandra StaufferDepartment of Pediatric Orthopaedics, Orthopaedic Hospital Speising, Vienna, Austria.
Andreas KranzlVienna Bone and Growth Center, Vienna, Austria.
Adalbert RaimannVienna Bone and Growth Center, Vienna, Austria.
Roland KocijanVienna Bone and Growth Center, Vienna, Austria.
Rudolf GangerDepartment of Pediatric Orthopaedics, Orthopaedic Hospital Speising, Vienna, Austria.
Gabriel T MindlerDepartment of Pediatric Orthopaedics, Orthopaedic Hospital Speising, Vienna, Austria.
Orthopaedic Hospital Speising · ATSigmund Freud University Vienna · ATMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: X-linked hypophosphatemia (OMIM 307800) is a rare bone disease caused by a phosphate-wasting condition with lifelong clinical consequences. Those affected suffer from bone pain, complex skeletal deformities, impaired mobility and a reduced quality of life. Early osteoarthritis and reduced range of motion of the lower limbs are known pathologies in XLH patients. However, XLH-specific data on the affected compartments such as the ankle joint through the evaluation of radiographic and gait analysis data is still lacking. Patients and methods: In this cross-sectional study, patients with genetically verified XLH, age ≥ 16 - 50 years and a complete record of gait analysis and or radiographic analysis data were included. Clinical examination, radiological and gait analysis data were compared to norms using the dataset of our gait laboratory registry. Radiographic analysis included tibial deformity analysis and assessment of osteoarthritis and enthesopathies. Western Ontario and McMaster Universities Arthritis Index (WOMAC), SF36v2, American Orthopedic Foot and Ankle Society score (AOFAS) and the Foot and Ankle Outcome Score (FAOS) were used. Twentythree participants with 46 limbs were eligible for the study. Results: A total of 23 patients (n=46 feet) met the inclusion criteria. Patients with XLH had significantly reduced gait quality, ankle power and plantar flexion (p < 0.001) compared to a historic gait laboratory control group. Ankle valgus deformity was detected in 22 % and ankle varus deformity in 30 % of the patients. The subtalar joint (59.1%) as well as the anterior tibiotalar joint (31.1%) were the main localizations of moderate to severe joint space narrowing. Ankle power was decreased in moderate and severe subtalar joint space narrowing (p < 0.05) compared to normal subtalar joint space narrowing. No lateral or medial ligament instability of the ankle joint was found in clinical examination. Tibial procurvatum deformity led to lower ankle power (p < 0.05). Conclusions: This study showed structural and functional changes of the ankle in patients with XLH. Subtalar ankle osteoarthritis, patient reported outcome scores and clinical ankle restriction resulted in lower gait quality and ankle power.

Indexed as

Familial Hypophosphatemic RicketsOsteoarthritisAdolescentAdultAnkleAnkle JointCross-Sectional StudiesHumansLower ExtremityMiddle AgedQuality of LifeYoung Adultankleankle powerdeformityenthesopathygait analysishypophosphatemiaosteoarthritisXLH

Identifiers

PMID37033213
PMCPMC10073673
OpenAlexW4353083343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.